4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001181431-15-008119
CIK 0001382911operating
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:36 PM ET
Size
5.7 KB
Accession
0001181431-15-008119
Insider Transaction Report
Form 4
Endicott David J.
Director
Transactions
- Award
Stock Option (right to buy)
2015-06-09+50,000→ 50,000 totalExercise: $4.63Exp: 2025-06-08→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]1/12th of the original number of shares of stock subject to the Option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of Reporting Person's service as a Director following the Vesting Commencement Date, such that the Option shall be 100% vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuing service on the board of directors through such dates. The shares subject to the Option shall vest on an accelerated basis in the event of the occurrence of a Change in Control as described in Section 3.1(c) of the Stock Option Agreement.
- [F2]Not applicable.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:36 PM ET
- Size
- 5.7 KB